New paradigm in the treatment of periodontitis: the microenvironment-responsive hydrogel

Chronic periodontitis is characterised by the formation of pathogenic bacterial biofilms within a hypoxic microenvironment. This oxygen depletion, coupled with anaerobic bacterial activity, constitutes a major obstacle to conventional treatments by hindering tissue regeneration. For the clinician, the difficulty lies in eliminating the infection while restoring favourable conditions for bone reconstruction.

The objective of this study is to develop and evaluate the efficacy of an injectable nanocomposite hydrogel designed for adaptive therapy. This device aims to directly modulate the local conditions of the periodontal pocket by reacting to specific bacterial metabolites.

The authors test the hypothesis that such a material can provide a sustained release of oxygen to counteract hypoxia, while acting as a sensor for hydrogen sulphide (H₂S), a by-product of anaerobic pathogens. The central hypothesis is based on the gel's ability to transform its chemical properties in situ to enhance its antibacterial action upon contact with H₂S, while promoting the osteogenic differentiation of periodontal ligament stem cells. This sequential strategy — oxygenation, on-demand infection control and regenerative activation — could offer a promising minimally invasive solution for the management of severe periodontitis.

Experimental design and engineering of the nanocomposite

This experimental study combines materials engineering, in vitro tests and in vivo validation in an animal model. The researchers synthesised an injectable hydrogel (PDA@Hb/NOCG) based on a dynamic Schiff base network. Its structure incorporates haemoglobin-polydopamine nanoparticles (PDA@Hb NPs) for oxygen release and an azide-terminated (N3) polyethylene glycol (PEG) responsive to hydrogen sulphide (H₂S).

• Adaptive mechanism: In the presence of H₂S (an anaerobic bacterial metabolite), the hydrogel undergoes an azide-to-amine chemical transformation, activating in situ an enhanced cationic antibacterial property.
• Microbiological and cellular evaluation: Antibacterial and antibiofilm activity was tested against Porphyromonas gingivalis, Escherichia coli and Staphylococcus aureus. Regenerative potential was evaluated on human periodontal ligament stem cells (hPDLSCs), specifically analysing the activation of the Wnt/β-catenin signalling pathway.
• In vivo model: Clinical efficacy was tested in a rat periodontitis model. Evaluation criteria included reduction of bacterial load, inflammatory infiltration and maintenance of alveolar bone.
• Analytical tools: Tissue regeneration was quantified by micro-computed tomography (micro-CT) and histological analyses, while biological safety was verified by systemic toxicity tests.

Biochemical reactivity and hypoxia control

The study of the dynamics of the PDA@Hb/NOCG nanocomposite reveals physicochemical properties adapted to the clinical constraints of periodontal injection. The network, cross-linked by a Schiff base, exhibits self-healing capabilities and sustained oxygen release via haemoglobin-polydopamine nanoparticles (PDA@Hb NPs).

The critical aspect of this technology lies in its response to hydrogen sulphide (H₂S), a key metabolite of anaerobic bacteria. In the presence of pathological levels of H₂S, the gel undergoes a chemical transformation of its azide groups into amines. This transition significantly increases the cationic charge in situ, enhancing the antibacterial activity on demand.

Antimicrobial and osteogenic efficacy in vitro

In vitro tests demonstrate an effective reduction of cellular hypoxia and robust activity against major periodontal pathogens. Activation of the Wnt/β-catenin signalling pathway has been identified as the central mechanism of osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs), even under inflammatory conditions.

In vivo results: bone preservation and safety

In a rat periodontitis model, the application of PDA@Hb/NOCG produced compelling clinical results following micro-CT and histology analysis:

• Reduction of bacterial load: Significant decrease in local bacterial presence.
• Modulation of inflammation: Notable reduction of inflammatory infiltration in periodontal tissues.
• Structural maintenance: Preservation of the alveolar bone structure compared to the control groups.
• Safety: Absence of systemic toxicity observed during histological analyses of major organs.

These data confirm that the gel executes a sequential therapeutic strategy: attenuation of hypoxia, targeted antibacterial reinforcement and pro-osteogenic activation.

Analysis of a smart hydrogel: towards adaptive therapy

The results of this study mark a turning point in the management of periodontitis by proposing a hydrogel that not only releases active agents but also interacts with the pathological microenvironment. By using hydrogen sulphide (H2S), a key metabolite of anaerobic bacteria, as a chemical trigger, the PDA@Hb/NOCG hydrogel transforms its azide groups into amines. This transformation enhances the antibacterial activity in situ precisely where the bacterial load is highest. Clinically, this specificity enables the targeting of major pathogens such as Porphyromonas gingivalis while minimising the impact on healthy tissues.

The regenerative efficacy observed in human periodontal ligament stem cells (hPDLSCs) relies on the activation of the Wnt/β-catenin pathway. Micro-CT analyses in a rat model confirm that this mechanism is not limited to a reduction in inflammation, but ensures actual maintenance of the alveolar bone. Unlike conventional approaches, the continuous oxygen supply via PDA@Hb nanoparticles counteracts tissue hypoxia, thereby overcoming one of the main obstacles to periodontal healing.

However, the study has limitations: the data are derived from a murine model and in vitro tests. Although systemic biocompatibility is established, the complexity of the human oral microbiome and the mechanical constraints of clinical periodontal pockets will require human trials to validate the long-term stability of the hydrogel.

Summary of results

This study demonstrates the efficacy of PDA@Hb/NOCG, an injectable hydrogel capable of releasing oxygen and activating its antibacterial properties specifically upon contact with bacterial H2S. In an animal model, this device significantly reduces the P. gingivalis load and preserves the alveolar bone architecture by stimulating osteogenic differentiation via the Wnt/β-catenin pathway.

In practical terms, for the practitioner:

• Smart bacterial targeting: This material only becomes cytotoxic to bacteria in the presence of their metabolites (H2S), offering a local "on-demand" antibacterial action without the systematic use of antibiotics.
• Recipient site optimisation: By correcting tissue hypoxia, the hydrogel transforms an unfavourable periodontal environment into a microenvironment conducive to active bone regeneration.
• Ease of application: Its injectable nature and self-healing properties allow for simplified placement in the treatment of deep periodontal pockets or complex intrabony defects.

Technical glossary of the study

PDA@Hb/NOCG: Injectable nanocomposite hydrogel reactive to hydrogen sulphide (H2S). It incorporates haemoglobin-polydopamine nanoparticles for oxygen release and an azide-terminated polyethylene glycol network for H2S capture.

Hydrogen sulphide (H2S): Gaseous metabolite characteristic of anaerobic periodontal infections. In this system, it acts as a pathological trigger activating the chemical transformation of the biomaterial.

Schiff base: Type of dynamic chemical bond used for the cross-linking of the hydrogel network. It provides the material with its injectability properties and self-healing capacity.

Azide-to-Amine Transformation: In situ chemical reaction triggered by the presence of H2S. This conversion modifies the polymer structure to increase its on-demand cationic antibacterial activity, specifically targeting the site of infection.

Wnt/β-catenin pathway: Intracellular signalling pathway involved in the regulation of cell growth. The hydrogel activates this cascade to promote the osteogenic differentiation of periodontal ligament stem cells (hPDLSCs) in an inflammatory environment.

hPDLSCs (human Periodontal Ligament Stem Cells): Human periodontal ligament stem cells. The study evaluates their ability to differentiate into bone tissue under the influence of the microenvironment regulated by the hydrogel.

PDA@Hb nanoparticles: Nanocomposites combining polydopamine and haemoglobin, acting as oxygen carriers to alleviate local tissue hypoxia associated with periodontitis.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims any liability regarding the use of this information. This document is not intended for patients or the general public.